Supplement
Lacticaseibacillus paracasei clinical trials
- studies test it
- 18
- open now
- 3
- in phase 3
- 1
- first study started
- 2015
Keep track of what changes. Save the Lacticaseibacillus paracasei studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- PS23
- 1
Other names
Studies by the year they started
18 studies that test it; most in 2019 (4)
| Year | Studies |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 4
- Phase 3
- 1
- Phase 4
- 2
- No phase
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 18
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2) · Charite University, Berlin, Germany (1) · Chi-Chang Huang (1) · The Affiliated Hospital of Qingdao University (1) · Aga Khan University (1) · Centre Hospitalier Universitaire de Nice (1) · University College, London (1) · Psychiatric Hospital of the University of Basel (1)
Often tested with
Tested in the same studies.
Streptococcus thermophilus (16) · Bifidobacterium breve (16) · Bifidobacterium animalis subsp. lactis (16) · Lacteol (16) · Lactobacillus plantarum (16) · Lactobacillus helveticus (16) · Linoleic Acids, Conjugated (1)
Studies
Open first, then newest update. How each study uses Lacticaseibacillus paracasei is read from its arms, and is right about nine times in ten.
Testing it · 18
- Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal JaundiceRecruitingPhase 2Chinese University of Hong KongNCT06087874Written as Vivomixx®
- Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple SclerosisRecruitingNot applicableUniversität MünsterNCT05920018Written as Vivomixx®
- Maternal Probiotic Intervention to Improve Gut HealthRecruitingPhase 2International Centre for Diarrhoeal Disease Research, BangladeshNCT06196450Written as Vivomixx
- An Open Label Trial Evaluating the Efficacy of Lacticaseibacillus Paracasei PS23 on CognitionCompletedNot applicableChi-Chang HuangNCT07168824Written as Lacticaseibacillus paracasei
- Fluoride vs Probiotic Toothpaste for Caries PreventionCompletedPhase 4The Affiliated Hospital of Qingdao UniversityNCT07579403Written as Probiotic Toothpaste
- Maternal Probiotic Intervention to Improve Gut HealthCompletedPhase 2Aga Khan UniversityNCT05922683Written as Vivomixx
- Effects of a Probiotic in HypertensionActive, not recruitingNot applicableCharite University, Berlin, GermanyNCT03906578Written as Vivomixx®
- Impact of Probiotics in HIV-positive Patients With Neurocognitive DisordersCompletedNot applicableCentre Hospitalier Universitaire de NiceNCT04175223Written as Vivomixx
- Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum DisorderCompletedNot applicableUniversity College, LondonNCT03369431Written as Vivomixx
- Probiotic Supplementation in Severe DepressionCompletedNot applicablePsychiatric Hospital of the University of BaselNCT02957591Written as Vivomixx®
- Pilot Study of Probiotics in Pre-diabetic AdolescentsCompletedNot applicableSeattle Children's HospitalNCT03109587Written as Vivomixx
- Effect of Probiotics (Vivomixx®) on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their NewbornCompletedPhase 4Hvidovre University HospitalNCT02508844Written as Vivomixx®
- Application of Oral Bacteriotherapy to Promote Anal HPV Clearance in HIV Positive IndividualsStatus unknownNot applicableUniversity of Roma La SapienzaNCT04099433Written as Vivomixx
- Can Probiotic Vivomixx Eradicate Colonization With ESBL?CompletedNot applicableLund UniversityNCT03860415Written as Vivomixx
- Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological ParametersCompletedNot applicableIRCCS Fondazione Stella MarisNCT02708901Written as Vivomixx®
- Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase InhibitorStatus unknownPhase 1/2Tel-Aviv Sourasky Medical CenterNCT03518268Written as Vivomixx
- Effect of Vivomixx® on Neuroinflammation in Patients Withs CirrhosisWithdrawnNot applicableFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNCT03236090Written as Vivomixx
- Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)WithdrawnPhase 3Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNCT02552862Written as Vivomixx®
Given in every arm · 1 — Lacticaseibacillus paracasei is usual care beside what is tested
Codes
What other systems call Lacticaseibacillus paracasei · ClinicalTrials.gg INT017346
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 2375526 | — | One source FDA |
| Wikidata | Q1799829 | Lacticaseibacillus paracasei | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.